TBPH

Theravance Biopharma, Inc.
17.03 +0.00% 2026-09-25 · 34d old

Last 90d 1 insider sale

52-week range
13.08 21.03
1-month+0.0%
3-month-3.4%
1-year+21.2%
3-year+88.0%
5-year+139.5%
vs 50-day+0.4%
vs 200-day-0.8%
Volatility44%
Beta0.51
$ vol/day$19M
ATH43.44
From ATH-60.8%
Nothing written about TBPH yet. Be the first — call it long or short with an entry we price for you, or post a neutral write-up that takes no side. Create a free account
2026AprJulOct

bought sold · bigger dot, bigger trade · follows the chart’s range

WhenPeople SizeValuePrice
1mo sched 1 $226,793 17.03
4mo sched 1 $218,183 16.66
7mo sched 1 $433,695 13.82
11mo sched 1 $582,506 18.66
11mo sched 1 $590,020 19.84
11mo sell 1 $809,250 17.34
12mo sell 1 $1,068,250 17.57
1.3y sched 1 $113,900 11.57
1.4y sched 1 $264,000 11.01
1.5y sched 1 $36,000 9.41
1.8y sched 1 $36,000 9.46
2.0y sell 1 $36,000 9.79
2.3y sched 1 $36,000 9.54
2.5y buy 1 $13,117,335 9.45
2.7y sched 1 $10,922 8.70
2.9y sched 1 $14,180 10.34
3.0y sched 1 $25,366 10.27
3.0y sched 1 $22,412 9.25
3.1y sched 1 $24,547 8.93
3.2y sched 1 $17,112 9.52
3.2y sched 1 $23,197 10.07
3.3y sell 1 $22,848 9.62
3.4y sell 1 $24,822 10.52
3.4y sell 1 $19,923 10.68
3.5y sell 1 $26,146 10.80
3.5y sell 1 $27,597 11.73
3.6y sell 1 $23,973 10.60
3.6y sell 1 $40,800 10.28
3.6y sell 1 $23,346 10.05
3.9y sell 1 $559,500 10.87
3.9y sell 1 $22,361 11.05
3.9y sell 1 $716,300 10.37
4.2y sell 1 $47,637 9.38
4.2y sell 1 $132,606 9.44
4.4y sell 1 $9,653 9.17
4.7y sell 1 $23,937 10.49
5.6y sell 1 $176,580 20.52
2026AprJulOct

bought sold · bigger dot, bigger trade · follows the chart’s range

GWGeorge Whitesides 1S 1.6y

1 member · 0 buys / 1 sells · $15K–$50K disclosed · latest filing Apr 23, 2025 · full tracker ›

WhenMemberSize AmountPrice then
1.6y sell GW George Whitesides $15K–$50K 9.39
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+0.2%
Next 1 week
+1.5%
Next 1 month
+1.8%
Seasonality
Bullish window historically
Next 30 days (to Nov 28): +8.2% median, 91% of the last 11 years finished up.
20-year seasonality chart →
Mean reversion
Neutral — RSI(2) at 40
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought. Its dip-buy edge in history is +0.08%/day.
Mean-reversion stats →
1-month breakdown — Market · β 0.51 +1.3% · Seasonal tilt (11y) +0.4%
$19M/day volume 44% volatility +21% 1-year -61% from ATH
52-week range · 50% of the way up · -19% from the high
$13.08$21.03

Not investment advice.